Abcam agrees all cash $24 per share offer less than a year after AIM delisting
Abcam agrees sale for $24 per shareSale comes less than one year after moving to Nasdaq from AIMCo-founder Jonathan Milner unsuccessful in wresting back controlLess than a year after delisting from AIM to move to Nasdaq life science...
29 August 2023